← Back to Vaccine Database

ARCT-021

RNA based vaccine · VDDBV0091

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials4

Note: 1 additional source trial listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04480957 Phase 2COVID-19
NCT04668339 Phase 2COVID-19
NCT04728347 Phase 2COVID-19
NCT05037097 Phase 2COVID-19